Iqvia's christina mack named 2023 pharmavoice 100 honoree

Research triangle park, n.c.--(business wire)--iqvia™ (nyse:iqv), a global provider of data, analytics, technology solutions and services to the life sciences industry, announced that dr. christina mack, chief scientific officer, has been named to the 2023 pharmavoice 100 list. the pharmavoice 100, an industry-acclaimed honor now in it's 18th year, recognizes trailblazers and leaders who have built and mentored innovative teams, developed breakthrough strategies, and worked toward solutions tha.
IQV Ratings Summary
IQV Quant Ranking